1400 related articles for article (PubMed ID: 19791840)
21. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
[TBL] [Abstract][Full Text] [Related]
22. Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy.
Kondrack R; Mohiuddin S
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1125-34. PubMed ID: 19689218
[TBL] [Abstract][Full Text] [Related]
23. Review: a single-pill combination of telmisartan plus amlodipine for the treatment of hypertension.
Guthrie RM
Postgrad Med; 2011 Nov; 123(6):58-65. PubMed ID: 22104454
[TBL] [Abstract][Full Text] [Related]
24. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
[TBL] [Abstract][Full Text] [Related]
25. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP
Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
Bhad P; Ayalasomayajula S; Karan R; Leon S; Riviere GJ; Sunkara G; Jarugula V
J Clin Pharmacol; 2011 Jun; 51(6):933-42. PubMed ID: 20852001
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
Neutel J; Shojaee A; Maa JF
Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and safety of the single pill combination of valsartan 80 mg plus amlodipine 5 mg in mild to moderate essential hypertensive patients without adequate blood pressure control by monotherapy].
Ke YN; Huang J; Zhu JR;
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Sep; 37(9):794-9. PubMed ID: 20128376
[TBL] [Abstract][Full Text] [Related]
29. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
30. Targeting hypertension with valsartan: Lessons learned from the Valsartan/HCTZ versus Amlodipine in stage II hypertensive patients (VASt) trial.
Ruilope LM; Zanchetti A
J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S8-11. PubMed ID: 16986228
[TBL] [Abstract][Full Text] [Related]
31. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
[TBL] [Abstract][Full Text] [Related]
32. Comparison of amlodipine/valsartan fixed-dose combination therapy and conventional therapy.
Malesker MA; Hilleman DE
Manag Care; 2010 Jul; 19(7):36-42. PubMed ID: 20672530
[TBL] [Abstract][Full Text] [Related]
33. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
34. Aliskiren and valsartan in stage 2 hypertension: subgroup analysis of a randomized, double-blind study.
Yarows SA; Oparil S; Patel S; Fang H; Zhang J
Adv Ther; 2008 Dec; 25(12):1288-302. PubMed ID: 19066757
[TBL] [Abstract][Full Text] [Related]
35. The VALUE trial: a commentary.
Sever P
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):99-101. PubMed ID: 15526243
[TBL] [Abstract][Full Text] [Related]
36. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
Saito I; Saruta T;
Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
[TBL] [Abstract][Full Text] [Related]
37. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
38. Two amlodipine/ARB combinations for hypertension.
Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
[No Abstract] [Full Text] [Related]
39. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
Weir MR; Levy D; Crikelair N; Rocha R; Meng X; Glazer R
Am J Hypertens; 2007 Jul; 20(7):807-15. PubMed ID: 17586417
[TBL] [Abstract][Full Text] [Related]
40. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
Barrios V; Escobar C
Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
